Authors

• Amy Evans
• Jenny Nelander
• Susann Ullén (ORCID: https://orcid.org/0000-0003-4854-9230)
• Olle Lindvall (ORCID: https://orcid.org/0000-0003-0702-8930)
• Bronwen Harry (ORCID: https://orcid.org/0000-0002-6938-567X)
• Paola Piccini (ORCID: https://orcid.org/0000-0003-4162-6141)
• Emma Cutting
• Anders Björklund (ORCID: https://orcid.org/0000-0002-5676-6203)
• Agnete Kirkeby (ORCID: https://orcid.org/0000-0001-8203-6901)
• Trinette van Vliet
• Gesine G. Paul
• Hjálmar Bjartmarz (ORCID: https://orcid.org/0000-0003-3944-8139)
• Oskar H. Hansson
• Håkan Widner
• Saeed Kayhanian
• Malin Parmar
• Roger A Barker
• Nicholas Lao-Kim
• Ruben Smith

Institutions

• University of Copenhagen (DK)
• Imperial College Healthcare NHS Trust (GB)
• Lund University (SE)
• Kristianstad University (SE)
• Wellcome/MRC Cambridge Stem Cell Institute (GB)
• University of Cambridge (GB)
• Novo Nordisk Foundation (DK)
• MRC Clinical Trials Unit at UCL (GB)
• Wallenberg Wood Science Center (SE)
• Skåne University Hospital (SE)
• Centralsjukhuset Kristianstad (SE)
• Imperial College London (GB)

Publication Details

Journal

BMJ Open

Published

2025-12-01

DOI

https://doi.org/10.1136/bmjopen-2025-107597

Primary Topic

Pluripotent Stem Cells Research

Type

article

Field-Weighted Citation Impact

0.00

Funders

• National Institute for Health and Care Research
• Department of Health and Social Care
• Lunds Universitet
• Novo Nordisk
• NIHR Cambridge Biomedical Research Centre